Dysregulation of the complement pathway—by genetic defects, mainly related to CFH or by autoimmune diseases, mainly related to autoantibodies (such as C3, C4, and C5 nephritic factors) against components of the pathway—results in C3 glomerulopathy. This evidence concerns the gene C3 and complement 3 glomerulopathy.